{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T18:15:07Z","timestamp":1783707307234,"version":"3.55.0"},"reference-count":17,"publisher":"Oxford University Press (OUP)","issue":"7","license":[{"start":{"date-parts":[[2011,7,1]],"date-time":"2011-07-01T00:00:00Z","timestamp":1309478400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,7,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Introduction<\/jats:title>\n                  <jats:p>Patients with diabetes mellitus (DM) are reported to experience more severe erectile dysfunction (ED) symptoms and respond less to ED treatments compared with patients with ED of other etiologies.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Aim<\/jats:title>\n                  <jats:p>This study was undertaken to evaluate the safety and efficacy of udenafil for the treatment of ED in a larger number of patients with DM.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>A placebo-controlled, randomized, double-blind, double-dummy, parallel-group design multicenter study, fixed-dose trial was conducted. The trial involved seven study sites in Korea, with 174 ED patients with DM. The subjects, treated with placebo, 100\u2003mg, or 200\u2003mg of udenafil for 12 weeks, were asked to complete the International Index of Erectile Function (IIEF), the Sexual Encounter Profile (SEP) diary, and the Global Assessment Question (GAQ) during the study period.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Main Outcome Measures<\/jats:title>\n                  <jats:p>The primary efficacy parameter was the change in the erectile function domain (EFD) score of IIEF from baseline. Secondary parameters were IIEF questions 3 (Q3) and Q4, SEP Q2 and Q3, rate of achieving normal erectile function (EFD\u2003\u2265\u200326), and the response to GAQ.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Compared with the placebo, patients receiving both doses of udenafil showed statistically significant improvements in the IIEF-EFD score, respectively. However, statistically significant difference was not observed between the udenafil 100\u2003mg and the udenafil 200\u2003mg groups. Similar results were observed in the comparison of Q3 and Q4 of IIEF, SEP diary, and GAQ. The percentages of subjects experiencing at least one adverse event related to the study drugs were 3.6%, 15.8%, and 22.4% for the placebo, udenafil 100\u2003mg, and udenafil 200\u2003mg groups, respectively. However, these events were all mild in severity. Major adverse events were flushing, headache, nausea, and conjunctival hyperemia.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>Udenafil was significantly effective for the treatment of ED, demonstrating statistically significant improvement in erectile function in patients with DM. The incidence of adverse events was relatively low and well tolerated in patients with DM.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1111\/j.1743-6109.2011.02268.x","type":"journal-article","created":{"date-parts":[[2011,5,6]],"date-time":"2011-05-06T17:34:37Z","timestamp":1304703277000},"page":"2048-2061","source":"Crossref","is-referenced-by-count":23,"title":["A Therapeutic Confirmatory Study to Assess the Safety and Efficacy of Zydena\u00ae (Udenafil) for the Treatment of Erectile Dysfunction in Male Patients with Diabetes Mellitus"],"prefix":"10.1093","volume":"8","author":[{"given":"Du Geon","family":"Moon","sequence":"first","affiliation":[{"name":"Department of Urology, College of Medicine, Korea University , Seoul, , Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dae Yul","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Urology, College of Medicine, Hallym University , Seoul, , Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Choong Hyun","family":"Lee","sequence":"additional","affiliation":[{"name":"Department of Urology, College of Medicine, Kyunghee University , Seoul, , Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tai Young","family":"Ahn","sequence":"additional","affiliation":[{"name":"Department of Urology, College of Medicine, Ulsan University , Seoul, , Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kweon Sik","family":"Min","sequence":"additional","affiliation":[{"name":"Paik Institute of Clinical Research, Inje University , Busan, , Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kwangsung","family":"Park","sequence":"additional","affiliation":[{"name":"Department of Urology, College of Medicine, Chonnam National University , Gwangju, , Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jong Kwan","family":"Park","sequence":"additional","affiliation":[{"name":"Department of Urology, Chonbuk National University, Medical School , Jeonju, , Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Je Jong","family":"Kim","sequence":"additional","affiliation":[{"name":"Department of Urology, College of Medicine, Korea University , Seoul, , Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2011,7,1]]},"reference":[{"key":"2023012308593343700_bb0010","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1007\/BF02976575","article-title":"Erectogenic effect of the selective phosphodiesterase type 5 inhibitor, DA-8159","volume":"23","author":"Oh","year":"2000","journal-title":"Arch Pharm Res"},{"key":"2023012308593343700_bb0015","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1111\/j.1743-6109.2007.00554.x","article-title":"Prevalence and risk factors for erectile dysfunction in Korean men: Results of an epidemiological study","volume":"4","author":"Ahn","year":"2007","journal-title":"J Sex Med"},{"key":"2023012308593343700_bb0020","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1007\/BF00251005","article-title":"The prevalence of diabetic impotence","volume":"18","author":"McCulloch","year":"1980","journal-title":"Diabetologia"},{"key":"2023012308593343700_bb0025","first-page":"598","article-title":"Diabetic neuropathy","volume":"26","author":"Rundles","year":"1950","journal-title":"Bull N Y Acad Med"},{"key":"2023012308593343700_bb0030","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1001\/jama.1958.03000050010003","article-title":"Impotence and diabetes mellitus","volume":"168","author":"Rubin","year":"1958","journal-title":"J Am Med Assoc"},{"key":"2023012308593343700_bb0035","doi-asserted-by":"crossref","first-page":"27H","DOI":"10.1016\/0002-9149(88)91102-2","article-title":"Sexual dysfunction in the diabetic patient with hypertension","volume":"61","author":"Zemel","year":"1988","journal-title":"Am J Cardiol"},{"key":"2023012308593343700_bb0040","article-title":"Text book of andrology","year":"2010"},{"key":"2023012308593343700_bb0045","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1007\/BF02977007","article-title":"Mechanism of erectogenic effect of the selective phosphodiesterase type 5 inhibitor, DA-8159","volume":"25","author":"Doh","year":"2002","journal-title":"Arch Pharm Res"},{"key":"2023012308593343700_bb0050","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1111\/j.1743-6109.2007.00723.x","article-title":"The efficacy and safety of udenafil, a new selective phosphodiesterase type 5 inhibitor, in patients with erectile dysfunction","volume":"5","author":"Paick","year":"2008","journal-title":"J Sex Med"},{"key":"2023012308593343700_bb0055","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1111\/j.1743-6109.2008.01168.x","article-title":"Erectile dysfunction in diabetes mellitus","volume":"6","author":"Malavige","year":"2009","journal-title":"J Sex Med"},{"key":"2023012308593343700_bb0060","doi-asserted-by":"crossref","first-page":"3166","DOI":"10.1111\/j.1743-6109.2009.01456.x","article-title":"The efficacy and safety of Udenafil [zydena] for the treatment of erectile dysfunction in hypertensive men taking concomitant antihypertensive agents","volume":"6","author":"Paick","year":"2009","journal-title":"J Sex Med"},{"key":"2023012308593343700_bb0065","first-page":"661","article-title":"Udenafil, a long-acting PDE5 inhibitor for erectile dysfunction","volume":"7","author":"Salem","year":"2006","journal-title":"Curr Opin Investig Drugs"},{"key":"2023012308593343700_bb0070","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1038\/aja.2009.27","article-title":"Increased expression of the nitric oxide synthase gene and protein in corpus cavernosum by repeated dosing of udenafil in a rat model of chemical diabetogenesis","volume":"11","author":"Ahn","year":"2009","journal-title":"Asian J Androl"},{"key":"2023012308593343700_bb0075","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.eururo.2004.06.005","article-title":"Efficacy of sildenafil citrate in treatment of erectile dysfunction: Effect of type 2 diabetes","volume":"46","author":"El-Sakka","year":"2004","journal-title":"Eur Urol"},{"key":"2023012308593343700_bb0080","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.2337\/diacare.25.12.2159","article-title":"Effects of tadalafil on erectile dysfunction in men with diabetes","volume":"25","author":"Saenz de Tejada","year":"2002","journal-title":"Diabetes Care"},{"key":"2023012308593343700_bb0085","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1111\/j.1743-6109.2006.00295.x","article-title":"Efficacy and safety of flexible-dose vardenafil in men with type 1 diabetes and erectile dysfunction","volume":"3","author":"Ziegler","year":"2006","journal-title":"J Sex Med"},{"key":"2023012308593343700_bb0090","doi-asserted-by":"crossref","first-page":"2125","DOI":"10.1111\/j.1743-6109.2008.00907.x","article-title":"Erectile dysfunction among men with diabetes is strongly associated with premature ejaculation and reduced libido","volume":"5","author":"Malavige","year":"2008","journal-title":"J Sex Med"}],"container-title":["The Journal of Sexual Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1743609515335815?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1743609515335815?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/jsm\/article-pdf\/8\/7\/2048\/48606190\/jsm_8_7_2048.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jsm\/article-pdf\/8\/7\/2048\/48606190\/jsm_8_7_2048.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,23]],"date-time":"2023-01-23T09:13:34Z","timestamp":1674465214000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jsm\/article\/8\/7\/2048\/6980155"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,7,1]]},"references-count":17,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2011,7,1]]},"published-print":{"date-parts":[[2011,7,1]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1743-6109.2011.02268.x","relation":{},"ISSN":["1743-6109","1743-6095"],"issn-type":[{"value":"1743-6109","type":"electronic"},{"value":"1743-6095","type":"print"}],"subject":[],"published-other":{"date-parts":[[2011,7]]},"published":{"date-parts":[[2011,7,1]]}}}